share_log

Alliance Global Partners Maintains Buy on Tonix Pharmaceuticals, Raises Price Target to $18

Benzinga ·  Jun 2, 2023 09:09

Alliance Global Partners analyst James Molloy maintains Tonix Pharmaceuticals (NASDAQ:TNXP) with a Buy and raises the price target from $6.5 to $18.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment